Wilbert van Duijnhoven, n/a

Janssen Pharmaceutica NV
Beerse, Brussels Hoofdstedelijk Gewest, Belgium

Disclosure(s): Janssen Pharmaceutica NV: Employee, Stocks/Bonds (Public Company)

Presentation(s):

• 573 - CD388, a Novel Drug-Fc Conjugate (DFC), Demonstrates Prophylactic Activity in an Influenza Human Challenge Model

  Saturday, October 19, 2024
  2:21 PM – 2:39 PM US PT